IP Library Assignment 033948/0928
Patent Assignment
Reel/Frame 033948/0928

Assignment of Assignor's Interest

Recorded: 2014-10-09 Pages: 14
Assignors
DAMSCHRODER, MELISSA
Executed: 2008-02-05
KIENER, PETER
Executed: 2008-02-05
WU, HERREN
Executed: 2008-02-05
DALL'ACQUA, WILLIAM
Executed: 2008-02-05
HERBST, RONALD
Executed: 2008-02-06
COYLE, ANTHONY
Executed: 2008-02-13
Assignee
MEDIMMUNE, INC.
ONE MEDIMMUNE WAY, GAITHERSBURG, MARYLAND, 20878
Covered Property (1)
Humanized Anti-CD19 Antibodies and Their Use in Treatment of Oncology, Transplantation and Autoimmune Disease
Patent: 9,896,505 →
Application: 14/509,457 →
Publication: US 2016/0145335
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Oct 9, 2014
From: MEDIMMUNE, INC.
To: MEDIMMUNE, LLC
Reel/Frame 033948/0960 →
Assignment of Assignor's Interest Apr 20, 2018
From: MEDIMMUNE, LLC
To: VIELA BIO, INC.
Reel/Frame 045604/0693 →
Security Agreement Mar 15, 2021
From: HORIZON ORPHAN LLC; HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
To: CITIBANK, N.A.
Reel/Frame 055659/0430 →
Release of Security Interest Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA HORIZON ORPHAN LLC); HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
Reel/Frame 065154/0064 →